BIO-RAD LABORATORIES, INC.

BIO NYSE CIK: 0000012208

Company Information

Industry Laboratory Analytical Instruments
SIC Code 3826
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 1000 ALFRED NOBEL DRIVE, HERCULES, CA, 94547
Mailing Address 1000 ALFRED NOBEL DRIVE, HERCULES, CA, 94547
Phone 5107247000
Fiscal Year End 1231
EIN 941381833

Financial Overview

FY2025

$3.12B
Total Liabilities
$9.62B
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report February 13, 2026 View on SEC
8-K Current report of material events February 12, 2026 View on SEC
4 Insider stock transaction report November 10, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment October 30, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment October 30, 2025 View on SEC
10-Q Quarterly financial report October 29, 2025 View on SEC
8-K Current report of material events October 29, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment October 28, 2025 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment October 28, 2025 View on SEC
4 Insider stock transaction report October 28, 2025 View on SEC

Annual Reports

10-K February 13, 2026
  • Bio-Rad reported strong financial results for 2025, with revenue up 5.2% to $2.95 billion and net income increasing 8.5% to $320 million.
  • The strategic acquisition of Stilla Technologies for $150 million significantly strengthens Bio-Rad's position in genomic research and advanced diagnostics.
View Analysis

Related Companies

Companies in the same industry (SIC: 3826)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.